A pyridinium‑type fullerene derivative suppresses primary effusion lymphoma cell viability via the downregulation of the Wnt signaling pathway through the destabilization of β‑catenin

Ayano Kadota(Kyoto Pharmaceutical University), Masahiro Fujimuro(Kyoto Pharmaceutical University), Yuichi Sekine(Kyoto Pharmaceutical University), Tadashi Watanabe(Aichi Medical University), Tadahiko Mashino(Keio University), Shigeo Nakamura(Nagoya University Hospital), Misato Moriguchi(Kyoto Pharmaceutical University), Takumi Yasuno(Keio University), Tomoyuki Ohe(Keio University)
Oncology Reports
January 5, 2022
Cited by 5


Related Papers